Tumor burden and heterogenous treatment effect of apalutamide in metastatic castration-sensitive prostate cancer.
Cancer · 2025-Apr-01 · PMID 40106307
PFS2
FIGURE 2 Inverse probability of treatment weighting‐adjusted Kaplan–Meier plots based on bone metastasis count. (A–F) Inverse probability of treatment weighting‐adjusted Kaplan–Meier plots by treatment, with subgroups based on bone metastasis count (one or two vs. three or more). Solid lines represent point estimates, and shaded areas represent 95% CIs. HRs were estimated based on inverse probability of treatment weighting‐adjusted Cox proportional hazards regression models. HRs < 1.0 favor apalutamide. CI indicates confidence interval; HR, hazard ratio; IPTW, inverse probability of treatment weighting; OS, overall survival; PFS, progression‐free survival; PFS2, second progression‐free survival; rPFS, radiographic progression‐free survival.
曲线数据
网页最多预览 200 行,完整数据请下载 CSV 或 JSON。
历史版本(1)
重跑只新增版本,不覆盖旧结果;正式可用状态仅授予通过 EXE 基准或人工复核的版本。
| 版本 | 状态 | 验证 | 曲线 | 时间 |
|---|---|---|---|---|
| legacy-0.5.0 | complete | 待验证 | 2 | 2026-07-18T20:20:34+00:00 |